Skip to main content

Table 6 Age-adjusted Incidence rate ratios for non cytophilic IgG with malaria incidence from low to the end of high malaria transmission season

From: Antibody responses to P. falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso

Antibodies/antigen Parasitemia > 0 Parasitemia > 2500 Parasitemia > 5000
Age adjusted (95% CI) p Age adjusted (95% CI) p Age adjusted (95% CI) p*
IgG2 MSP3 1.02 (0.963, 1.080) 0.50 1.04 (0.964, 1.113) 0.34 1.04 (0.965, 1.121) 0.3
  MSP2a 0.98 (0.923, 1.042) 0.53 0.96 (0.889, 1.033) 0.27 0.95 (0.879, 1.027) 0.2
  MSP2b 0.94 (0.877, 1.011) 0.095 0.87 (0.798, 0.950) 0.002 0.87 (0.791, 0.947) 0.002
  GLURP-R0 1.00 (0.954, 1.054) 0.92 0.99 (0.927, 1.054) 0.72 1.00 (0.935, 1.066) 0.958
  GLURP-R2 0.98 (0.959, 1.008) 0.17 0.96 (0.931, 0.992) 0.013 0.97 (0.934, 0.997) 0.034
IgG4 MSP3 0.95 (0.886, 1.014) 0.12 0.90 (0.824, 0.987) 0.024 0.90 (0.819, 0.988) 0.03
  MSP2a 0.98 (0.950, 1.011) 0.21 0.97 (0.935, 1.012) 0.16 0.97 (0.931, 1.011) 0.15
  MSP2b 0.98 (0.957, 1.007) 0.16 0.97 (0.934, 0.998) 0.038 0.96 (0.925, 0.992) 0.015
  GLURP-R0 0.98 (0.939, 1.023) 0.35 0.99 (0.941, 1.046) 0.78 0.97 (0.922, 1.030) 0.37
  GLURP-R2 0.94 (0.899, 0.990) 0.02 0.89 (0.826, 0.949) 0.0006 0.88 (0.818, 0.947) 0.0006
  1. *  p ≤ 0.05 was considered as statistically significant
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us